Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 368

1.

Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg).

Algorta J, Diaz M, de Benito R, Lefebvre M, Sicard E, Furtado M, Regidor PA, Ronchi C.

Eur J Contracept Reprod Health Care. 2017 Dec;22(6):429-438. doi: 10.1080/13625187.2017.1413179. Epub 2018 Jan 16.

PMID:
29336615
2.

Simultaneous determination of etonogestrel and ethinyl estradiol in human plasma by UPLC-MS/MS and its pharmacokinetic study.

Nair SG, Patel DP, Gonzalez FJ, Patel BM, Singhal P, Chaudhary DV.

Biomed Chromatogr. 2018 May;32(5):e4165. doi: 10.1002/bmc.4165. Epub 2018 Jan 19.

PMID:
29228469
3.

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.

Hasegawa S, Matsui T, Hane Y, Abe J, Hatahira H, Motooka Y, Sasaoka S, Fukuda A, Naganuma M, Hirade K, Takahashi Y, Kinosada Y, Nakamura M.

PLoS One. 2017 Jul 21;12(7):e0182045. doi: 10.1371/journal.pone.0182045. eCollection 2017.

4.

Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.

Morotti E, Casadio P, Guasina F, Battaglia B, Mattioli M, Battaglia C.

Gynecol Endocrinol. 2017 Aug;33(8):660-664. doi: 10.1080/09513590.2017.1306850. Epub 2017 Apr 17.

PMID:
28412867
5.

Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.

Haaland RE, Holder A, Evans-Strickfaden T, Nyagol B, Makanga M, Oyaro B, Humwa F, Williams T, McLellan-Lemal E, Desai M, Huey MJ.

Contraception. 2017 Jun;95(6):602-604. doi: 10.1016/j.contraception.2017.03.011. Epub 2017 Apr 1.

6.

Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis.

López-Picado A, Lapuente O, Lete I.

Eur J Contracept Reprod Health Care. 2017 Apr;22(2):131-146. doi: 10.1080/13625187.2017.1287351. Epub 2017 Feb 14. Review.

PMID:
28256919
7.

Stroke and Etonogestrel/Ethinyl Estradiol Ring (NuvaRing): Clinical, Radiological, and Prognostic Features.

Selvan P, Piran P, Balucani C, Tark B, Adler Z, Levine SR.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):608-617. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.111. Epub 2016 Dec 29.

PMID:
28041897
8.

Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial.

De Giglio L, Marinelli F, Barletta VT, Pagano VA, De Angelis F, Fanelli F, Petsas N, Pantano P, Tomassini V, Pozzilli C.

CNS Drugs. 2017 Feb;31(2):161-168. doi: 10.1007/s40263-016-0401-0.

PMID:
27995531
9.

Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.

Priya K, Rajaram S, Goel N.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:141-146. doi: 10.1016/j.ejogrb.2016.10.026. Epub 2016 Nov 8.

PMID:
27863271
10.

Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial.

Fan GS, Ren M, Di W, Su P, Chang Q, Wu S, Qin Y, Korver T, Marintcheva-Petrova M, Yacik C, McCrary Sisk C, Wang G.

Eur J Contracept Reprod Health Care. 2016 Aug;21(4):303-9. doi: 10.1080/13625187.2016.1186269. Epub 2016 Jun 24.

PMID:
27339759
11.

Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study.

Peters K, Gordon N, Ricciotti N, Hsieh J, Howard B, Weiss H.

Clin Exp Obstet Gynecol. 2016;43(3):334-40.

PMID:
27328486
12.

Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.

Dahiya P, Dalal M, Yadav A, Dahiya K, Jain S, Silan V.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:147-51. doi: 10.1016/j.ejogrb.2016.05.009. Epub 2016 May 20.

PMID:
27285306
13.

Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study.

Feldman R, Frenkl TL, Yacik C, Wang Y, Fox MC.

Contraception. 2016 Oct;94(4):362-5. doi: 10.1016/j.contraception.2016.04.017. Epub 2016 May 17.

PMID:
27207028
14.

Rationale for eliminating the hormone-free interval in modern oral contraceptives.

London A, Jensen JT.

Int J Gynaecol Obstet. 2016 Jul;134(1):8-12. doi: 10.1016/j.ijgo.2015.10.028. Epub 2016 Mar 20. Review.

15.

High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents.

Kancheva Landolt N, Bunupuradah T, Kosalaraksa P, Ubolyam S, Thammajaruk N, Cremers S, Zott R, Kerr S, Ananworanich J; HIV-NAT 176 study.

J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):507-12. doi: 10.1097/QAI.0000000000000997.

PMID:
26990825
16.

Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol.

Kroll R, Ackerman R, Feldman R, Howard B, Weiss H, Hsieh J, Ricciotti N.

Contraception. 2016 Mar;93(3):249-56. doi: 10.1016/j.contraception.2015.10.007. Epub 2015 Oct 20.

PMID:
26499407
17.

Adult-onset Sydenham's chorea or drug-induced movement disorder? A case report.

Delaruelle Z, Honoré PJ, Santens P.

Acta Neurol Belg. 2016 Sep;116(3):399-400. doi: 10.1007/s13760-015-0537-6. Epub 2015 Sep 4. No abstract available.

PMID:
26341343
18.

Effect of a combined oral contraceptive on patency of arterial anastomosis in a female rat model.

Dadaci M, Oztekin C, Oztekin PS, Sargon MF, Ozgur F.

Microsurgery. 2015 Oct;35(7):553-9. doi: 10.1002/micr.22474. Epub 2015 Aug 25.

PMID:
26303979
19.

Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study.

Agarwal N, Gupta M, Kriplani A, Bhatla N, Singh N.

J Obstet Gynaecol. 2016;36(1):71-5. doi: 10.3109/01443615.2015.1024210. Epub 2015 Jul 23.

PMID:
26204126
20.

Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.

Glintborg D, Sidelmann JJ, Altinok ML, Mumm H, Andersen M.

Metabolism. 2015 Oct;64(10):1272-8. doi: 10.1016/j.metabol.2015.06.011. Epub 2015 Jun 17.

PMID:
26194691

Supplemental Content

Loading ...
Support Center